These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22110765)

  • 21. Trends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemic.
    Pineda-Peña AC; Schrooten Y; Vinken L; Ferreira F; Li G; Trovão NS; Khouri R; Derdelinckx I; De Munter P; Kücherer C; Kostrikis LG; Nielsen C; Littsola K; Wensing A; Stanojevic M; Paredes R; Balotta C; Albert J; Boucher C; Gomez-Lopez A; Van Wijngaerden E; Van Ranst M; Vercauteren J; Vandamme AM; Van Laethem K
    PLoS One; 2014; 9(7):e101738. PubMed ID: 25003369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug resistance in antiretroviral-naive children newly diagnosed with HIV-1 in Manaus, Amazonas.
    Andrade SD; Sabidó M; Monteiro WM; Benzaken AS; Tanuri A
    J Antimicrob Chemother; 2017 Jun; 72(6):1774-1783. PubMed ID: 28333295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increase in transmitted drug resistance in migrants from sub-Saharan Africa diagnosed with HIV-1 in Sweden.
    Andersson E; Nordquist A; Esbjörnsson J; Flamholc L; Gisslén M; Hejdeman B; Marrone G; Norrgren H; Svedhem V; Wendahl S; Albert J; Sönnerborg A
    AIDS; 2018 Apr; 32(7):877-884. PubMed ID: 29369826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012.
    Yang WL; Kouyos R; Scherrer AU; Böni J; Shah C; Yerly S; Klimkait T; Aubert V; Furrer H; Battegay M; Cavassini M; Bernasconi E; Vernazza P; Held L; Ledergerber B; Günthard HF;
    J Infect Dis; 2015 Jul; 212(1):28-38. PubMed ID: 25576600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of transmitted antiretroviral drug resistance in treatment-naive HIV-1-infected persons in a large South Central United States clinic.
    Kleyn TJ; Liedtke MD; Harrison DL; Lockhart SM; Salvaggio MR; Ripley TL; Rathbun RC
    Ann Pharmacother; 2014 Apr; 48(4):470-5. PubMed ID: 24473489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia.
    Balode D; Westman M; Kolupajeva T; Rozentale B; Albert J
    J Med Virol; 2010 Dec; 82(12):2013-8. PubMed ID: 20981787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surveillance of transmitted HIV-1 antiretroviral drug resistance in the context of decentralized HIV care in Senegal and the Ebola outbreak in Guinea.
    Mbange AE; Kaba D; Diouara AAM; Diop-Ndiaye H; Ngom-Ngueye NF; Dieng A; Lo S; Toure KN; Fall M; Mbacham WF; Diallo MS; Cisse M; Mboup S; Kane CT
    BMC Res Notes; 2018 Oct; 11(1):723. PubMed ID: 30309385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal Trends in HIV-1 Mutations Used for the Surveillance of Transmitted Drug Resistance.
    Rhee SY; Tzou PL; Shafer RW
    Viruses; 2021 May; 13(5):. PubMed ID: 34064774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolution of HIV-1 transmitted drug resistance in Italy in the 2007-2014 period: A weighted analysis.
    Franzetti M; De Luca A; Ceccherini-Silberstein F; Spagnuolo V; Nicastri E; Mussini C; Antinori A; Monno L; Vecchiet J; Fanti I; d'Arminio Monforte A; Balotta C;
    J Clin Virol; 2018 Sep; 106():49-52. PubMed ID: 30075459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transmitted HIV drug resistance among individuals with newly diagnosed HIV infection: a multicenter observational study.
    Ye J; Hao M; Xing H; Zhang F; Wu H; Lv W; Jiang T; Wang Y; Wang J; Feng Y; Xin R; Zeng J; Zhao S; Hao Y; Chen J; Ruan Y; Li X; Shao Y; Lu H
    AIDS; 2020 Mar; 34(4):609-619. PubMed ID: 31895143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transmitted antiretroviral drug resistance in the men who have sex with men HIV patient cohort, Beijing, China, 2008-2011.
    Dai L; Li N; Wei F; Li J; Liu Y; Xia W; Zhang T; Guo C; Wang W; Schwartz SA; Mahajan SD; Hsiao CB; Wu H
    Viral Immunol; 2014 Oct; 27(8):392-7. PubMed ID: 25084305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High burden of transmitted HIV-1 drug resistance in Italian patients carrying F1 subtype.
    Franzetti M; Lai A; Simonetti FR; Bozzi G; De Luca A; Micheli V; Meraviglia P; Corsi P; Bagnarelli P; Almi P; Zoncada A; Balotta C
    J Antimicrob Chemother; 2012 May; 67(5):1250-3. PubMed ID: 22302564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy: evolution over 12 years and predictors.
    Bracciale L; Colafigli M; Zazzi M; Corsi P; Meraviglia P; Micheli V; Maserati R; Gianotti N; Penco G; Setti M; Di Giambenedetto S; Butini L; Vivarelli A; Trezzi M; De Luca A
    J Antimicrob Chemother; 2009 Sep; 64(3):607-15. PubMed ID: 19608581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV drug resistance and HIV transmission risk factors among newly diagnosed individuals in Southwest China.
    Pang X; Tang K; He Q; Huang J; Fang N; Zhou X; Zhu Q; Wu X; Shen Z; Liang S
    BMC Infect Dis; 2021 Feb; 21(1):160. PubMed ID: 33557775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of HIV-1 transmitted drug resistance in recently infected, treatment-naïve persons in the Southwest of Iran, 2014-2015.
    Ghafari S; Memarnejadian A; Samarbaf-Zadeh A; Mostafavi E; Makvandi M; Salmanzadeh S; Ghadiri A; Jordan MR; Mousavi E; Jahanbakhsh F; Azadmanesh K
    Arch Virol; 2017 Sep; 162(9):2737-2745. PubMed ID: 28589513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.
    de Mulder M; Yebra G; Martín L; Prieto L; Mellado MJ; Rojo P; Muñoz-Fernández MÁ; Jiménez de Ory S; Ramos JT; Holguín A;
    J Antimicrob Chemother; 2011 Oct; 66(10):2362-71. PubMed ID: 21810838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiological Surveillance of HIV-1 Transmitted Drug Resistance in Spain in 2004-2012: Relevance of Transmission Clusters in the Propagation of Resistance Mutations.
    Vega Y; Delgado E; Fernández-García A; Cuevas MT; Thomson MM; Montero V; Sánchez M; Sánchez AM; Pérez-Álvarez L;
    PLoS One; 2015; 10(5):e0125699. PubMed ID: 26010948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transmitted antiretroviral drug resistance in New York State, 2006-2008: results from a new surveillance system.
    Readhead AC; Gordon DE; Wang Z; Anderson BJ; Brousseau KS; Kouznetsova MA; Forgione LA; Smith LC; Torian LV
    PLoS One; 2012; 7(8):e40533. PubMed ID: 22879878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategies.
    Frange P; Assoumou L; Descamps D; Chéret A; Goujard C; Tran L; Gousset M; Avettand-Fenoël V; Bocket L; Fafi-Kremer S; Guinard J; Morand-Joubert L; Nicot F; Plantier JC; Rogez S; Wirden M; Rouzioux C; Meyer L; Chaix ML; ;
    J Antimicrob Chemother; 2015 Jul; 70(7):2084-9. PubMed ID: 25885327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low prevalence of transmitted drug resistance of HIV-1 during 2008-2012 antiretroviral therapy scaling up in Southern Vietnam.
    Tanuma J; Quang VM; Hachiya A; Joya A; Watanabe K; Gatanaga H; Van Vinh Chau N; Chinh NT; Oka S
    J Acquir Immune Defic Syndr; 2014 Aug; 66(4):358-64. PubMed ID: 24815852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.